MD
Pediatrix Medical·NYSE
--
--(--)
--
--(--)
8.79 / 10
Outperform
The stock's fundamentals show robust quality (8.8/10). Favorable features: Net income-Revenue and Basic earnings per share (YoY growth rate %), despite concerns regarding Revenue-MV and Cash-MV. Analytical stance: superior.
Analysis Checks(6/10)
Revenue-MV
Value0.95
Score1/3
Weight2.69%
1M Return0.59%
Value0.95
Score1/3
Weight2.69%
1M Return0.59%
Net income-Revenue
Value0.11
Score2/3
Weight12.05%
1M Return2.86%
Value0.11
Score2/3
Weight12.05%
1M Return2.86%
Total profit (YoY growth rate %)
Value226.86
Score3/3
Weight29.86%
1M Return6.14%
Value226.86
Score3/3
Weight29.86%
1M Return6.14%
Diluted earnings per share (YoY growth rate %)
Value198.72
Score3/3
Weight24.82%
1M Return5.10%
Value198.72
Score3/3
Weight24.82%
1M Return5.10%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value201.66
Score3/3
Weight19.68%
1M Return4.09%
Value201.66
Score3/3
Weight19.68%
1M Return4.09%
Net cash flow from operating activities per share (YoY growth rate %)
Value113.49
Score2/3
Weight6.36%
1M Return1.41%
Value113.49
Score2/3
Weight6.36%
1M Return1.41%
Basic earnings per share (YoY growth rate %)
Value200.00
Score3/3
Weight22.95%
1M Return4.75%
Value200.00
Score3/3
Weight22.95%
1M Return4.75%
Net cash flow from operating activities (YoY growth rate %)
Value113.41
Score1/3
Weight2.59%
1M Return0.62%
Value113.41
Score1/3
Weight2.59%
1M Return0.62%
Asset-MV
Value-0.50
Score0/3
Weight-20.57%
1M Return-3.95%
Value-0.50
Score0/3
Weight-20.57%
1M Return-3.95%
Cash-MV
Value1.13
Score1/3
Weight-0.45%
1M Return-0.11%
Value1.13
Score1/3
Weight-0.45%
1M Return-0.11%
Revenue-MV
Value0.95
Score1/3
Weight2.69%
1M Return0.59%
Value0.95
Score1/3
Weight2.69%
1M Return0.59%
Net cash flow from operating activities per share (YoY growth rate %)
Value113.49
Score2/3
Weight6.36%
1M Return1.41%
Value113.49
Score2/3
Weight6.36%
1M Return1.41%
Net income-Revenue
Value0.11
Score2/3
Weight12.05%
1M Return2.86%
Value0.11
Score2/3
Weight12.05%
1M Return2.86%
Basic earnings per share (YoY growth rate %)
Value200.00
Score3/3
Weight22.95%
1M Return4.75%
Value200.00
Score3/3
Weight22.95%
1M Return4.75%
Total profit (YoY growth rate %)
Value226.86
Score3/3
Weight29.86%
1M Return6.14%
Value226.86
Score3/3
Weight29.86%
1M Return6.14%
Net cash flow from operating activities (YoY growth rate %)
Value113.41
Score1/3
Weight2.59%
1M Return0.62%
Value113.41
Score1/3
Weight2.59%
1M Return0.62%
Diluted earnings per share (YoY growth rate %)
Value198.72
Score3/3
Weight24.82%
1M Return5.10%
Value198.72
Score3/3
Weight24.82%
1M Return5.10%
Asset-MV
Value-0.50
Score0/3
Weight-20.57%
1M Return-3.95%
Value-0.50
Score0/3
Weight-20.57%
1M Return-3.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value201.66
Score3/3
Weight19.68%
1M Return4.09%
Value201.66
Score3/3
Weight19.68%
1M Return4.09%
Cash-MV
Value1.13
Score1/3
Weight-0.45%
1M Return-0.11%
Value1.13
Score1/3
Weight-0.45%
1M Return-0.11%
Is MD undervalued or overvalued?
- MD scores 8.79/10 on fundamentals and holds a Discounted valuation at present. Backed by its 15.91% ROE, 8.44% net margin, 16.32 P/E ratio, 2.01 P/B ratio, and 162.87% earnings growth, these metrics solidify its Outperform investment rating.
